<SUBMISSION>
<SECRELEASE-DATETIME> 20070706-175922 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20070706-175922 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20070706-172734 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001193125-07-151114
<TYPE> T-3
<PUBLIC-DOCUMENT-COUNT> 3
<FILING-DATE> 20070706
<DATE-OF-FILING-DATE-CHANGE> 20070706
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> INDEVUS PHARMACEUTICALS INC
<CIK> 0000854222
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 043047911 ⇒ 04-3047911 or 043-04-7911
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 0930
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> T-3
<ACT> 39
<FILE-NUMBER> 022-28838
<FILM-NUMBER> 07968110
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 33 HAYDEN AVENUE
<CITY> LEXINGTON
<STATE> MA
<ZIP> 02421
<PHONE> 6178618444
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 33 HAYDEN AVENUE
<CITY> LEXINGTON
<STATE> MA
<ZIP> 02421
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> INTERNEURON PHARMACEUTICALS INC
<DATE-CHANGED> 19920703
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> T-3
<SEQUENCE> 1
<FILENAME> dt3.htm
<DESCRIPTION> FORM T-3
<TEXT>
<HTML>
Show <HTML>: 653 lines (widest: 249 characters) - 62K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.T.3.C
<SEQUENCE> 2
<FILENAME> dex99t3c.htm
<DESCRIPTION> FORM OF INDENTURE
<TEXT>
<HTML>
Show <HTML>: 3,552 lines (widest: 249 characters) - 426K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.T.3.G
<SEQUENCE> 3
<FILENAME> dex99t3g.htm
<DESCRIPTION> STATEMENT OF ELIGIBILITY
<TEXT>
<HTML>
Show <HTML>: 549 lines (widest: 249 characters) - 41K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
